Cargando…

Identification of Dutch children diagnosed with atopic diseases using prescription data: a validation study

PURPOSE: The aim of this study is to validate medication proxies for the identification of children diagnosed with atopic disorders that can be applied in various types of epidemiological research. METHODS: Records of 7439 children, aged between 0 and 10 years, in the period 2001 until 2010, were re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mulder, B, Groenhof, F, Kocabas, L I, Bos, HJ, De Vries, TW, Hak, E, Schuiling-Veninga, CCM
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2015
Materias:	Pharmacoepidemiology and Prescription
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701779/ https://www.ncbi.nlm.nih.gov/pubmed/26450360 http://dx.doi.org/10.1007/s00228-015-1940-x

Ejemplares similares

Ten years after the Dutch public health campaign on folic acid: the continuing challenge
por: de Walle, Hermien E. K., et al.
Publicado: (2008)

Defining antimicrobial prescribing quality indicators: what is a new prescription?
por: Boesten, Jos, et al.
Publicado: (2010)

Vitamin D deficiency as adverse drug reaction? A cross-sectional study in Dutch geriatric outpatients
por: van Orten-Luiten, A. C. B., et al.
Publicado: (2016)

Prescription of antibacterial agents for acute upper respiratory tract infections in Beijing, 2010–2012
por: Wu, Yiqun, et al.
Publicado: (2015)

The 10-year trend in drug prescriptions for attention-deficit/hyperactivity disorder (ADHD) in Germany
por: Grimmsmann, Thomas, et al.
Publicado: (2020)

Potentially inappropriate prescribing in older hospitalized Dutch patients according to the STOPP/START criteria v2: a longitudinal study
por: Damoiseaux-Volman, Birgit A., et al.
Publicado: (2020)

The interplay of context factors in hypnotic and sedative prescription in primary and secondary care—a qualitative study
por: Weiß, Vivien, et al.
Publicado: (2018)

Prescription analgesia and adjuvant use by pain severity at admission among nursing home residents with non-malignant pain
por: Lapane, Kate L., et al.
Publicado: (2020)

Who gets prescriptions for proton pump inhibitors and why? A drug-utilization study with claims data in Bavaria, Germany, 2010–2018
por: Rückert-Eheberg, Ina-Maria, et al.
Publicado: (2021)

In utero exposure to antidepressants and the use of drugs for pulmonary diseases in children
por: ter Horst, P. G. J., et al.
Publicado: (2012)

Clinical relevance of potentially inappropriate medications and potential prescribing omissions according to explicit criteria—a validation study
por: Parodi López, Naldy, et al.
Publicado: (2022)

Number of drugs in the medication list as an indicator of prescribing quality: a validation study of polypharmacy indicators in older hip fracture patients
por: Belfrage, Björn, et al.
Publicado: (2015)

Do medical students copy the drug treatment choices of their teachers or do they think for themselves?
por: Tichelaar, J., et al.
Publicado: (2009)

A novel approach to teaching pharmacotherapeutics—feasibility of the learner-centered student-run clinic
por: Dekker, Ramon S., et al.
Publicado: (2015)

Prior outpatient antibiotic use as predictor for microbial aetiology of community-acquired pneumonia: hospital-based study
por: van de Garde, Ewoudt MW, et al.
Publicado: (2007)

Medication administered to children from 0 to 7.5 years in the Avon Longitudinal Study of Parents and Children (ALSPAC)
por: Headley, J., et al.
Publicado: (2007)

How useful are prescribing indicators based on the DU90% method to distinguish the quality of prescribing between pharmacotherapy audit meetings with different levels of functioning?
por: Teichert, Martina, et al.
Publicado: (2007)

Evaluation of patients’ experiences with antidepressants reported by means of a medicine reporting system
por: van Geffen, E. C. G., et al.
Publicado: (2007)

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands
por: van Hunsel, Florence, et al.
Publicado: (2010)

Frequency of laboratory measurement and hyperkalaemia in hospitalised patients using serum potassium concentration increasing drugs
por: Uijtendaal, Esther V., et al.
Publicado: (2011)

Regulatory scientific advice in drug development: does company size make a difference?
por: Putzeist, Michelle, et al.
Publicado: (2010)

Discrepancies between prescribed and defined daily doses: a matter of patients or drug classes?
por: Grimmsmann, Thomas, et al.
Publicado: (2011)

The use of driving impairing medicines: a European survey
por: Ravera, Silvia, et al.
Publicado: (2009)

The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports
por: Derijks, Hieronymus J., et al.
Publicado: (2008)

Predictors of orphan drug approval in the European Union
por: Heemstra, Harald E., et al.
Publicado: (2008)

Pharmacovigilance in children in Camagüey Province, Cuba
por: Bárzaga Arencibia, Z., et al.
Publicado: (2012)

Effects of codeine on pregnancy outcome: results from a large population-based cohort study
por: Nezvalová-Henriksen, Kateřina, et al.
Publicado: (2011)

Dopamine agonists and ischemic complications in Parkinson’s disease: a nested case–control study
por: Arbouw, Maurits E. L., et al.
Publicado: (2011)

Systematic review of safety in paediatric drug trials published in 2007
por: Nor Aripin, Khairun Nain Bin, et al.
Publicado: (2011)

Appropriateness of treatment recommendations for PPI in hospital discharge letters
por: Ahrens, Dirk, et al.
Publicado: (2010)

The use of opioids at the end of life: knowledge level of pharmacists and cooperation with physicians
por: Borgsteede, Sander D., et al.
Publicado: (2010)

Pattern of asthma medication use among children from a large urban center in Brazil
por: Santos, Djanilson Barbosa, et al.
Publicado: (2011)

Unintended consequences of reducing QT-alert overload in a computerized physician order entry system
por: van der Sijs, Heleen, et al.
Publicado: (2009)

Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson’s disease
por: Arbouw, Maurits E. L., et al.
Publicado: (2009)

Medication errors in the Middle East countries: A systematic review of the literature
por: Alsulami, Zayed, et al.
Publicado: (2012)

The role of Periodic Safety Update Reports in the safety management of biopharmaceuticals
por: Ebbers, Hans C., et al.
Publicado: (2012)

Intensive monitoring of duloxetine: results of a web-based intensive monitoring study
por: Härmark, Linda, et al.
Publicado: (2012)

Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and z-drugs consumption in nine European countries
por: Clay, Emilie, et al.
Publicado: (2012)

Role of pharmacoepidemiology studies in addressing pharmacovigilance questions: a case example of pancreatitis risk among ulcerative colitis patients using mesalazine
por: Russo, Leo, et al.
Publicado: (2014)

Reducing the noise in signal detection of adverse drug reactions by standardizing the background: a pilot study on analyses of proportional reporting ratios-by-therapeutic area
por: Grundmark, Birgitta, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_meg9ij7qfvsslosf3jdg4f6o3d